Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS BSE: AAREYDRUGS
NSE
71.27
4.15 (6.18%)
Prev Close
67.12
Open Price
66.3
Volume
457,200
Today Low / High
66.3 / 71.93
52 WK Low / High
32.85 / 100
Range
68 - 75
BSE
70.65
4.10 (6.16%)
Prev Close
66.55
Open Price
69.73
Volume
4,929
Today Low / High
67.09 / 71.5
52 WK Low / High
31.3 / 100
Range
67 - 74
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 71.27 (target range: 68 - 75), reflecting a change of 4.15 (6.18296%). On the BSE, it is listed at 70.65 (target range: 67 - 74), showing a change of 4.1 (6.16078%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
17 Feb
65.77
2.05%
16 Feb
66.65
-0.35%
13 Feb
69.87
-4.14%
12 Feb
66.75
6.28%
11 Feb
65.66
3.52%
10 Feb
69.50
-6.00%
09 Feb
67.18
3.80%
06 Feb
66.48
1.05%
05 Feb
64.95
1.02%
04 Feb
64.99
-3.40%
03 Feb
64.00
1.48%
02 Feb
64.22
-0.33%
01 Feb
67.00
-4.04%
30 Jan
69.77
-3.11%
29 Jan
70.74
0.58%
28 Jan
69.96
1.11%
27 Jan
66.13
2.69%
23 Jan
65.44
5.09%
22 Jan
65.97
-0.67%
21 Jan
63.45
2.16%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 71.27, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 70.65 | 71.36 | 64.22 - 78.49 |
| 72.06 | 57.65 - 86.48 | ||
| 72.77 | 50.94 - 94.60 | ||
| Bearish Scenario | 70.65 | 69.94 | 62.95 - 76.94 |
| 69.24 | 55.39 - 83.08 | ||
| 68.53 | 47.97 - 89.09 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
221,150
Market Cap
1,903,140,817
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
111.17
DCF
-45
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 473.94 Cr | 464.81 Cr | 9.13 Cr | 0.0193 | 0.00 Cr | 1.34 Cr | 0.31 Cr | 4.02 Cr | 1.43 | 12.06 Cr | 0.0085 |
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 418.96 Cr | 403.84 Cr | 11.51 Cr | 0.0275 | 0.00 Cr | 0.88 Cr | 13.53 Cr | 3.77 Cr | 1.49 | 10.45 Cr | 0.0090 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 11.77 Cr | 6.55 Cr | 2.72 | 14.06 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 3.87 Cr | 6.51 Cr | 2.79 | 11.67 Cr | 0.0187 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 238.27 Cr | 99.79 Cr | 138.4805 Cr | 34.86 Cr | 33.38 Cr | 45.48 Cr | 16.22 Cr | 0.00 Cr | 0.00 Cr | 3.10 Cr | 96.8804 Cr |
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 65.18 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 1.19 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 56.12 Cr | 14.47 Cr | 0.89 Cr | 0.00 Cr | 2.80 Cr | 126.7362 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 46.93 Cr | 14.26 Cr | 0.00 Cr | 0.00 Cr | 0.40 Cr | 130.8039 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.8948 Cr | -5.9394 Cr | 4.9237 Cr | -4.3096 Cr | -0.1211 Cr | 1.4733 Cr | -5.2044 Cr | 4.0239 Cr | 3.2337 Cr | 0.0000 Cr | -10.8045 Cr |
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 2.2534 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | -3.9786 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 84.16 Cr | 81.36 Cr | 2.80 Cr | 0.0333 | 1.95 Cr | 1.02 Cr | 0.36 | 3.44 Cr | 0.0122 |
| 2025-06-30 | 102.21 Cr | 97.84 Cr | 4.37 Cr | 0.0428 | 1.22 Cr | 1.37 Cr | 0.48 | 3.25 Cr | 0.0134 |
| 2025-03-31 | 108.10 Cr | 108.02 Cr | 0.08 Cr | 0.0007 | -3.43 Cr | 0.47 Cr | 0.17 | 2.69 Cr | 0.0043 |
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
| 2024-09-30 | 105.14 Cr | 98.90 Cr | 6.24 Cr | 0.0594 | 3.23 Cr | 1.60 Cr | 0.57 | 3.74 Cr | 0.0152 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.19 Cr | 1.00 Cr | 8.19 Cr | 122.34 Cr | 39.12 Cr | 256.36 Cr | 25.09 Cr | 294.00 Cr | 145.15 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 3.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -138.48 Cr |
| 2025-03-31 | 1.47 Cr | 0.00 Cr | 1.47 Cr | 159.55 Cr | 45.48 Cr | 213.28 Cr | 16.22 Cr | 238.27 Cr | 99.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -135.59 Cr |
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 23.52 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,724.40 | ₹4,137,413,222,268.00 | ₹1,262,170.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,283.50 | ₹1,668,071,822,430.00 | ₹438,667.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,210.80 | ₹1,425,126,058,752.00 | ₹347,893.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,280.30 | ₹1,065,937,053,657.00 | ₹689,990.00 |
| Lupin Limited | LUPIN | ₹2,226.70 | ₹1,017,530,525,358.00 | ₹381,509.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹910.05 | ₹915,723,242,600.00 | ₹291,231.00 |
| Mankind Pharma Limited | MANKIND | ₹2,075.60 | ₹856,818,207,443.00 | ₹211,149.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,159.60 | ₹673,497,562,031.00 | ₹3,294,003.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,464.00 | ₹653,303,160,000.00 | ₹83,553.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,030.20 | ₹572,924,082,432.00 | ₹352,142.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,037.45 | ₹560,074,210,996.00 | ₹1,427,154.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,490.60 | ₹378,171,507,351.00 | ₹75,106.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,961.90 | ₹370,046,824,726.00 | ₹85,287.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,984.10 | ₹318,502,704,019.00 | ₹232,902.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,463.00 | ₹277,344,626,020.00 | ₹46,167.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,433.40 | ₹232,916,275,045.00 | ₹569,422.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,886.00 | ₹222,150,000,000.00 | ₹3,172.00 |
| Eris Lifesciences Limited | ERIS | ₹1,344.60 | ₹183,157,231,639.00 | ₹30,605.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,620.00 | ₹174,743,088,180.00 | ₹43,615.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹890.50 | ₹159,497,339,235.00 | ₹1,067,406.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹775.30 | ₹152,395,390,037.00 | ₹34,929.00 |
| Granules India Limited | GRANULES | ₹582.40 | ₹141,330,260,198.00 | ₹850,473.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹889.50 | ₹140,869,890,846.00 | ₹92,618.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,711.50 | ₹130,094,017,704.00 | ₹114,514.00 |
| Cohance Lifesciences Limited | COHANCE | ₹325.85 | ₹124,659,502,569.00 | ₹9,235,891.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹899.10 | ₹110,351,937,600.00 | ₹21,088.00 |
| Viyash Scientific Limited | VIYASH | ₹223.97 | ₹97,696,959,049.00 | ₹538,456.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,018.00 | ₹83,295,698,876.00 | ₹7,438.00 |
| Strides Pharma Science Limited | STAR | ₹877.10 | ₹80,844,687,449.00 | ₹365,132.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹487.85 | ₹74,690,838,995.00 | ₹431,045.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹721.90 | ₹65,438,278,651.00 | ₹93,098.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹328.80 | ₹64,307,301,101.00 | ₹186,914.00 |
| FDC Limited | FDC | ₹379.15 | ₹61,729,443,349.00 | ₹58,724.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹132.21 | ₹42,904,999,149.00 | ₹351,056.00 |
| Innova Captab Limited | INNOVACAP | ₹687.90 | ₹39,365,028,659.00 | ₹16,454.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹340.75 | ₹37,129,914,049.00 | ₹403,562.00 |
| Suven Life Sciences Limited | SUVEN | ₹152.55 | ₹34,701,158,700.00 | ₹141,838.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹374.25 | ₹34,157,797,500.00 | ₹79,614.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹664.25 | ₹33,690,165,496.00 | ₹20,221.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,945.90 | ₹32,183,269,289.00 | ₹10,368.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹295.65 | ₹29,648,522,899.00 | ₹45,302.00 |
Key Executives
Chief Accountant
A. S. Kathawala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mihir Rajesh Ghatalia
Gender: male
Year Born: 1983
Executive Director
Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
Chief Financial Officer
Mira Mihir Ghatalia
Gender: female
Year Born:
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mihir Rajesh Ghatalia.
What is the current market price of the stock?
The current price is ₹67.12.
What is the 52-week price range?
The range is ₹32.85-100.
What is the market capitalization of the company?
The market capitalization is ₹190.31 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 53.27.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹190.31 crores and an average daily volume of 221,150 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.